ISA is a Netherlands-based biopharmaceutical company that develops and commercializes cellular immunotherapies for the treatment of cancer and SARS diseases.
Business Model:
Revenue: $10M
Employees: 11-50
Address: Leiden Bio Science Park
City: Oegstgeest
State: zuid-holland
Zip: 2342 DH
Country: NL
ISA is a Netherlands-based biopharmaceutical company that develops and commercializes cellular immunotherapies for the treatment of cancer and SARS diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2021 | Equity | $30.8M |
Invest-NL Regeneron |
10/2019 | Debt | $22.1M |
European Investment Bank |
1/2013 | Equity | $10.5M | 1/2013 | Venture Round | $10.5M | 7/2021 | Venture Round | $30.6M | 10/2019 | Debt Financing | 1 | $22.1M |
European Investment Bank European Investment Bank |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|